Other News To Note
Tuesday, December 27, 2011
Compass Biotechnologies Inc., of Edmonton, Alberta, formed four operational divisions to develop and commercialize products in women's reproductive health; hepatitis antiviral drugs and prophylactic vaccines; recombinant protein therapeutics called biobetters; and cytokine reagents, diagnostics and growth factor supplements for the cell culture and biotech manufacturing industries. The company said it engaged advisors to raise approximately $5 million as a bridge financing in the first quarter of 2012, with a larger secondary offering expected later in the year.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.